Gilles W. De Keulenaer
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease.
Journal: American journal of physiology. Heart and circulatory physiology
Published: May 19, 2026
ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease.
Journal: American journal of physiology. Heart and circulatory physiology
Published: May 19, 2026
Neuregulin-1β augments adaptive concentric remodeling and systolic function without exacerbating hypertrophy during pressure overload.
Journal: American journal of physiology. Heart and circulatory physiology
Published: February 03, 2026
Neuregulin-1β Augments Adaptive Concentric Remodeling and Systolic Function Without Exacerbating Hypertrophy during Pressure-Overload.
Journal: American journal of physiology. Heart and circulatory physiology
Published: February 03, 2026
Quality standards for preclinical research in cardio-oncology.
Journal: European heart journal
Published: November 30, 2025
ERBB4 activation as a new therapy for atrial remodeling and fibrillation.
Journal: Heart rhythm
Published: October 23, 2025
The role of angiotensin II in cardiovascular disease-induced cancer growth.
Journal: Cardio-oncology (London, England)
Published: August 18, 2025
Breast cancer progression in the presence of treated and untreated left ventricular dysfunction.
Journal: Cardio-oncology (London, England)
Published: March 27, 2025
Invasive Coronary Physiology Assessment in Patients With Arrhythmia-Induced Cardiomyopathy.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: March 18, 2025
Benchmarking of computational demultiplexing methods for single-nucleus RNA sequencing data.
Journal: Briefings in bioinformatics
Published: November 12, 2024
Exercise training for cardiovascular prevention in patients with cancer.
Journal: European heart journal
Published: August 08, 2024
Small-molecule-induced ERBB4 activation to treat heart failure.
Journal: Nature communications
Published: March 29, 2024
Last Updated: 09/26/2026